Analyst Articles – US

Zacks Investment Research Lowers CymaBay Therapeutics (CBAY) to Sell

CymaBay Therapeutics (NASDAQ:CBAY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday. According to Zacks, “CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company’s lead […]

Cineplex (CPXGF) Rating Lowered to Market Perform at BMO Capital Markets

BMO Capital Markets cut shares of Cineplex (OTCMKTS:CPXGF) from an outperform rating to a market perform rating in a research report released on Monday morning, MarketBeat reports. Cineplex (OTCMKTS CPXGF) traded down $1.03 during midday trading on Monday, reaching $25.97. The company’s stock had a trading volume of 803 shares, compared to its average volume […]

Deutsche Bank Raises Splunk (SPLK) Price Target to $100.00

Splunk (NASDAQ:SPLK) had its price target raised by Deutsche Bank to $100.00 in a report published on Monday. The brokerage currently has a buy rating on the software company’s stock. Several other analysts also recently issued reports on SPLK. Drexel Hamilton restated a buy rating and set a $93.00 price objective on shares of Splunk […]

Zacks Investment Research Downgrades Macerich (MAC) to Sell

Zacks Investment Research cut shares of Macerich (NYSE:MAC) from a hold rating to a sell rating in a report released on Monday morning. According to Zacks, “Shares of Macerich have underperformed the industry in the past six months. Moreover, the stock has seen the Zacks Consensus Estimate for full-year 2017 and 2018 funds from operations […]

DTE Energy (DTE) Lifted to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of DTE Energy (NYSE:DTE) from a hold rating to a buy rating in a research report sent to investors on Monday. Zacks Investment Research currently has $116.00 price target on the utilities provider’s stock. According to Zacks, “In last one year DTE Energy’s share price outperformed the broader industry’s rally. […]

Atmos Energy (ATO) Downgraded by Zacks Investment Research to “Sell”

Atmos Energy (NYSE:ATO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday. According to Zacks, “Atmos Energy Corporation, together with its subsidiaries, engages in the distribution, transmission, and storage of natural gas in the United States. It operates in three segments: […]

Alamos Gold Inc (US) (AGI) Given a $9.00 Price Target by Royal Bank of Canada Analysts

Royal Bank of Canada set a $9.00 price objective on Alamos Gold Inc (US) (NYSE:AGI) (TSE:AGI) in a research report released on Monday. The firm currently has a hold rating on the basic materials company’s stock. Other equities analysts have also issued reports about the company. Zacks Investment Research upgraded Alamos Gold Inc (US) from […]

CDW’s (CDW) Buy Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reissued their buy rating on shares of CDW (NASDAQ:CDW) in a report released on Monday morning. Royal Bank of Canada currently has a $80.00 price objective on the information technology services provider’s stock. Other equities research analysts have also issued reports about the stock. Morgan Stanley raised their price objective on […]

Numis Securities Lowers GKN (GKNLY) to Hold

Numis Securities cut shares of GKN (OTCMKTS:GKNLY) from a buy rating to a hold rating in a research note released on Monday, Marketbeat.com reports. A number of other equities analysts also recently issued reports on the stock. Zacks Investment Research raised shares of GKN from a sell rating to a hold rating in a report […]

Ladder Capital (LADR) Upgraded at Bank of America

Ladder Capital (NYSE:LADR) was upgraded by analysts at Bank of America from a “neutral” rating to a “buy” rating in a report issued on Tuesday, The Fly reports. A number of other research firms also recently issued reports on LADR. BidaskClub downgraded Ladder Capital from a “hold” rating to a “sell” rating in a report […]

Western Gas Partners’ (WES) Buy Rating Reaffirmed at Royal Bank of Canada

Western Gas Partners (NYSE:WES)‘s stock had its “buy” rating reiterated by Royal Bank of Canada in a report released on Tuesday. They currently have a $61.00 price objective on the pipeline company’s stock. Royal Bank of Canada’s price objective would suggest a potential upside of 13.26% from the company’s current price. Several other brokerages have […]

Ashford (AINC) Downgraded by Zacks Investment Research to “Sell”

Ashford (NYSEAMERICAN:AINC) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday. According to Zacks, “Ashford Inc. is a provider of asset management and other services to companies within the hospitality industry. It is focused on managing real estate, hospitality, and securities platforms. The Company […]

Zacks Investment Research Downgrades Nutrien (NTR) to Hold

Zacks Investment Research cut shares of Nutrien (NYSE:NTR) from a strong-buy rating to a hold rating in a research report released on Friday. According to Zacks, “Nutrien Ltd. produces and sells fertilizers and related industrial and feed products. The company’s products primarily include standard and granular potash; diammonium phosphate, monoammonium phosphate and phosphoric acid and […]

Solar Capital (SLRC) Upgraded to Outperform by Keefe, Bruyette & Woods

Solar Capital (NASDAQ:SLRC) was upgraded by equities research analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a note issued to investors on Friday, MarketBeat reports. The firm currently has a $23.00 price objective on the financial services provider’s stock. Keefe, Bruyette & Woods’ target price indicates a […]

Wingstop (WING) Price Target Increased to $44.00 by Analysts at Barclays

Wingstop (NASDAQ:WING) had its price objective raised by stock analysts at Barclays from $36.00 to $44.00 in a report released on Tuesday. The brokerage currently has an “equal weight” rating on the restaurant operator’s stock. Barclays’ target price indicates a potential downside of 1.17% from the stock’s current price. Several other brokerages have also recently […]

Snap (SNAP) Upgraded by Vetr to Strong-Buy

Vetr upgraded shares of Snap (NYSE:SNAP) from a buy rating to a strong-buy rating in a research note released on Monday morning. The firm currently has $15.96 target price on the stock. SNAP has been the topic of a number of other reports. JPMorgan Chase & Co. restated a neutral rating and set a $14.00 […]

Ovid Therapeutics (OVID) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Ovid Therapeutics (NASDAQ:OVID) from a hold rating to a buy rating in a research report released on Friday morning. The brokerage currently has $11.00 price objective on the stock. According to Zacks, “Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological […]

Danaher (DHR) Stock Rating Reaffirmed by Robert W. Baird

Robert W. Baird reaffirmed their buy rating on shares of Danaher (NYSE:DHR) in a research note published on Friday morning. Several other research firms have also recently commented on DHR. Zacks Investment Research cut shares of Danaher from a buy rating to a hold rating in a research note on Tuesday, December 19th. Credit Suisse […]

Reading International (RDI) Rating Increased to Hold at Zacks Investment Research

Reading International (NASDAQ:RDI) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday. According to Zacks, “Reading International, Inc. is engaged primarily in the ownership and management of commercial and residential property. “ A number of other analysts also recently commented on the company. […]

Hain Celestial Group (HAIN) Lifted to “Hold” at Zacks Investment Research

Hain Celestial Group (NASDAQ:HAIN) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday. According to Zacks, “Hain Celestial shares have underperformed the industry in the past three months. Stiff competition from companies expanding their presence in the natural & organic food business and foreign […]

Nice (NICE) Downgraded to Hold at Zacks Investment Research

Nice (NASDAQ:NICE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Friday. According to Zacks, “NICE Ltd. provides enterprise software solutions. Its operating segment consists of Customer Interactions Solutions, Financial Crime and Compliance Solutions. The Company’s solutions include integrated, multimedia recording platforms, […]

Nantkwest (NK) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Nantkwest (NASDAQ:NK) from a hold rating to a buy rating in a research note issued to investors on Friday. The brokerage currently has $5.00 price target on the biotechnology company’s stock. According to Zacks, “NantKwest, Inc. is a clinical-stage immunotherapy company. The Company’s product candidates include aNK, haNK and […]

BNP Paribas (BNPQY) Cut to “Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of BNP Paribas (OTCMKTS:BNPQY) from a hold rating to a sell rating in a report issued on Monday. According to Zacks, “BNP PARIBAS is a European leader in global banking and financial services and is one of the four strongest banks in the world according to Standard & Poor’s. The […]

Canadian Natural Resource’s (CNQ) “Buy” Rating Reaffirmed at AltaCorp Capital

AltaCorp Capital reaffirmed their buy rating on shares of Canadian Natural Resource (NYSE:CNQ) (TSE:CNQ) in a research note released on Monday morning. They currently have a $52.00 target price on the oil and gas producer’s stock. A number of other equities analysts also recently weighed in on the company. Morgan Stanley boosted their price target […]

Zacks Investment Research Lowers Pearson (PSO) to Hold

Pearson (NYSE:PSO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday. According to Zacks, “Pearson is a global media conglomerate. They publish books, periodicals, reports and screen-based services for professional communities worldwide, under brand names which include the Financial Times, Pitman Publishing and […]

Crescent Point Energy (CPG) Receives Buy Rating from AltaCorp Capital

Crescent Point Energy (NYSE:CPG) (TSE:CPG)‘s stock had its “buy” rating reissued by equities research analysts at AltaCorp Capital in a research note issued on Monday. They currently have a $16.25 price target on the oil and gas producer’s stock. AltaCorp Capital’s target price suggests a potential upside of 79.36% from the company’s previous close. Several […]

Oramed Pharmaceuticals’ (ORMP) Buy Rating Reiterated at B. Riley

Oramed Pharmaceuticals (NASDAQ:ORMP)‘s stock had its “buy” rating reaffirmed by stock analysts at B. Riley in a note issued to investors on Tuesday. They currently have a $20.00 price target on the biotechnology company’s stock. B. Riley’s price objective suggests a potential upside of 129.89% from the stock’s current price. Other equities analysts also recently […]

First Majestic Silver’s (AG) “Buy” Rating Reaffirmed at HC Wainwright

First Majestic Silver (NYSE:AG) (TSE:FR)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research note issued to investors on Tuesday. They currently have a $14.00 price target on the mining company’s stock. HC Wainwright’s price target would indicate a potential upside of 94.17% from the company’s current price. A number […]

Deciphera Pharmaceuticals (DCPH) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research lowered shares of Deciphera Pharmaceuticals (NASDAQ:DCPH) from a buy rating to a hold rating in a report issued on Monday morning. According to Zacks, “Deciphera Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib which are in […]

Zacks Investment Research Downgrades Cybg (CBBYF) to Hold

Zacks Investment Research downgraded shares of Cybg (OTCMKTS:CBBYF) from a buy rating to a hold rating in a report published on Monday. According to Zacks, “CYBG PLC provides commercial banking services to retail and institutional customers. It offers savings accounts, telephone banking, insurance, investment management, loans, credit cards, cash management accounts, financial planning, mortgage and […]

Royal Gold (RGLD) PT Set at $90.00 by Scotiabank

Scotiabank set a $90.00 target price on Royal Gold (NASDAQ:RGLD) (TSE:RGL) in a research note issued to investors on Monday morning. The brokerage currently has a hold rating on the basic materials company’s stock. Several other research analysts have also issued reports on the stock. Zacks Investment Research lowered shares of Royal Gold from a […]

HP (HPQ) Given New $26.00 Price Target at UBS Group

HP (NYSE:HPQ) had its target price lifted by stock analysts at UBS Group from $24.00 to $26.00 in a research note issued to investors on Tuesday, 99wallstreet.com reports. The brokerage currently has a “neutral” rating on the computer maker’s stock. UBS Group’s target price points to a potential upside of 13.44% from the company’s current […]

Caretrust REIT (CTRE) Given a $19.00 Price Target by Stephens Analysts

Stephens set a $19.00 price objective on Caretrust REIT (NASDAQ:CTRE) in a report issued on Friday morning. The firm currently has a buy rating on the real estate investment trust’s stock. Several other brokerages have also issued reports on CTRE. Stifel Nicolaus reiterated a hold rating and issued a $19.00 price target (up previously from […]

Miragen Therapeutics (MGEN) Coverage Initiated by Analysts at Oppenheimer

Oppenheimer started coverage on shares of Miragen Therapeutics (NASDAQ:MGEN) in a report released on Friday. The brokerage issued an outperform rating and a $13.00 price target on the medical research company’s stock. A number of other analysts have also weighed in on the stock. Wedbush reissued a buy rating and issued a $19.00 price objective […]

Dynatronics (DYNT) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research cut shares of Dynatronics (NASDAQ:DYNT) from a buy rating to a hold rating in a report released on Friday. According to Zacks, “DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. “ Dynatronics (NASDAQ DYNT) traded down $0.03 on Friday, hitting $3.15. […]

Jazz Pharmaceuticals (JAZZ) Upgraded by Zacks Investment Research to Hold

Zacks Investment Research upgraded shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) from a sell rating to a hold rating in a research note issued to investors on Friday. According to Zacks, “Jazz lowered its earnings guidance for 2017, mainly due to lower-than-expected sales from Xyrem. Xyrem is facing patent challenges in the United States. Jazz has also […]

Retail Opportunity Investments (ROIC) Cut to Sell at BidaskClub

BidaskClub lowered shares of Retail Opportunity Investments (NASDAQ:ROIC) from a hold rating to a sell rating in a report released on Saturday morning. Several other analysts have also recently commented on the stock. Jefferies Group cut shares of Retail Opportunity Investments from a buy rating to a hold rating and dropped their target price for […]

athenahealth (ATHN) Earns Buy Rating from KeyCorp

KeyCorp reaffirmed their buy rating on shares of athenahealth (NASDAQ:ATHN) in a report issued on Friday. They currently have a $152.00 price target on the health services provider’s stock. ATHN has been the subject of a number of other research reports. Cantor Fitzgerald reiterated a hold rating and set a $120.00 price target on shares […]

Advance Auto Parts (AAP) Upgraded to Buy at Zacks Investment Research

Advance Auto Parts (NYSE:AAP) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. The brokerage presently has a $130.00 price target on the stock. Zacks Investment Research‘s price target suggests a potential upside of 13.69% from the company’s current […]

Noble (NE) Given a $5.00 Price Target by Susquehanna Bancshares Analysts

Susquehanna Bancshares set a $5.00 price objective on Noble (NYSE:NE) in a research report report published on Friday. The brokerage currently has a hold rating on the oil and gas company’s stock. Several other analysts have also recently weighed in on NE. Cowen set a $5.00 price objective on shares of Noble and gave the […]

RPC (RES) Rating Reiterated by Wells Fargo & Co

Wells Fargo & Co reiterated their market perform rating on shares of RPC (NYSE:RES) in a report issued on Friday morning, MarketBeat.com reports. A number of other equities research analysts have also recently weighed in on the company. Jefferies Group set a $25.00 price target on RPC and gave the company a hold rating in […]

KB Home (KBH) Downgraded to Underperform at Buckingham Research

Buckingham Research cut shares of KB Home (NYSE:KBH) from a neutral rating to an underperform rating in a report released on Friday, MarketBeat.com reports. The firm currently has $34.00 target price on the construction company’s stock, up from their prior target price of $28.00. The analysts noted that the move was a valuation call. A […]

Iberdrola (IBDRY) Stock Rating Upgraded by Societe Generale

Iberdrola (OTCMKTS:IBDRY) was upgraded by analysts at Societe Generale from a “hold” rating to a “buy” rating in a report issued on Tuesday. Separately, JPMorgan Chase & Co. lowered shares of Iberdrola from an “overweight” rating to a “neutral” rating in a research note on Tuesday, October 3rd. Five investment analysts have rated the stock […]

GameStop (GME) Given a $26.00 Price Target at Loop Capital

Loop Capital set a $26.00 price objective on GameStop (NYSE:GME) in a report published on Friday morning. The firm currently has a buy rating on the stock. GME has been the topic of a number of other reports. Zacks Investment Research cut GameStop from a buy rating to a hold rating in a report on […]

Sonoco Products (SON) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of Sonoco Products (NYSE:SON) from a hold rating to a buy rating in a research report sent to investors on Friday. Zacks Investment Research currently has $61.00 price objective on the industrial products company’s stock. According to Zacks, “For 2017, Sonoco's earnings per share guidance range is at $2.75-$2.81, the […]

Verizon Communications (VZ) Downgraded to “Neutral” at Moffett Nathanson

Verizon Communications (NYSE:VZ) was downgraded by research analysts at Moffett Nathanson from a “buy” rating to a “neutral” rating in a report issued on Tuesday. A number of other equities research analysts have also recently issued reports on VZ. Cowen reissued a “hold” rating and issued a $52.00 price target on shares of Verizon Communications […]

TESARO (TSRO) Price Target Cut to $156.00 by Analysts at Morgan Stanley

TESARO (NASDAQ:TSRO) had its price target lowered by analysts at Morgan Stanley from $165.00 to $156.00 in a note issued to investors on Tuesday. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s price objective points to a potential upside of 140.96% from the company’s previous close. Several other brokerages […]

Nautilus (NLS) Rating Increased to Buy at Zacks Investment Research

Nautilus (NYSE:NLS) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday. The firm currently has a $15.00 price objective on the specialty retailer’s stock. Zacks Investment Research‘s price target would indicate a potential upside of 13.21% from the stock’s previous close. […]

Zacks Investment Research Downgrades Nantkwest (NK) to Hold

Nantkwest (NASDAQ:NK) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday. According to Zacks, “NantKwest, Inc. is a clinical-stage immunotherapy company. The Company’s product candidates include aNK, haNK and taNK for the treatment of cancers, infectious and inflammatory diseases. It is focused on […]

Viacom (VIAB) Raised to “Hold” at BidaskClub

BidaskClub upgraded shares of Viacom (NASDAQ:VIAB) from a sell rating to a hold rating in a research note issued to investors on Saturday. A number of other brokerages also recently issued reports on VIAB. Piper Jaffray Companies reaffirmed a hold rating and issued a $40.00 price objective on shares of Viacom in a research report […]